Open AccessLong-Term Bioavailability After a Single Oral or Intramuscular Administration of 600,000 IU of Ergocalciferol or Cholecalciferol: Implications for Treatment and Prophylaxis
Author(s) -
Cristiana Cipriani,
Elisabetta Romagnoli,
Jessica Pepe,
Stefania Russo,
Luciano Carlucci,
Sara Piemonte,
Luciano Nieddu,
Donald J. McMahon,
Ravinder J. Singh,
Salvatore Minisola
Publication year - 2013
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2013-1586
Subject(s) - cholecalciferol , ergocalciferol , vitamin d and neurology , medicine , bioavailability , endocrinology , vitamin d deficiency , vitamin , pharmacokinetics , chemistry , pharmacology
We previously showed that a single high dose of oral (po) cholecalciferol (D₃) sharply increases serum 25-hydroxyvitamin D [25(OH)D].
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom